Vdo Biotech

Executive Summary

Vdo Biotech is a Chinese high-tech enterprise focused on innovative microsphere technologies for diagnostic applications. Founded in 2020 and based in Suzhou, the company develops and manufactures high-quality microsphere products used in various diagnostic platforms and research applications. With a team of 10-50 employees, Vdo Biotech targets the growing in vitro diagnostics (IVD) market in China, leveraging its expertise in microsphere synthesis and surface modification to provide reliable solutions for life sciences and clinical diagnostics. The company is currently in the commercial stage, indicating it has launched products and generates revenue, though financial details and valuation are not publicly disclosed. As a private entity, Vdo Biotech may seek partnerships or funding to scale production and expand its product portfolio, particularly in the rapidly expanding Chinese IVD sector, which benefits from increasing healthcare demand and government support for local innovation.

Upcoming Catalysts (preview)

• 2026Launch of New Multiplex Diagnostic Microsphere Panel70% success
• 2026Strategic Partnership with Leading Chinese Diagnostic Company60% success
• 2026Regulatory Approval for Microsphere-based IVD Reagent50% success